ALAB
Income statement / Annual
Last year (2024), Astera Labs, Inc. Common Stock's total revenue was $396.29 M,
an increase of 242.24% from the previous year.
In 2024, Astera Labs, Inc. Common Stock's net income was -$83.42 M.
See Astera Labs, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$396.29 M |
$115.79 M |
$79.87 M |
| Cost of Revenue |
$93.59 M
|
$35.97 M
|
$21.19 M
|
| Gross Profit |
$302.70 M
|
$79.83 M
|
$58.68 M
|
| Gross Profit Ratio |
0.76
|
0.69
|
0.73
|
| Research and Development Expenses |
$200.83 M
|
$73.41 M
|
$73.71 M
|
| General & Administrative Expenses |
$94.28 M
|
$15.93 M
|
$20.76 M
|
| Selling & Marketing Expenses |
$123.65 M
|
$19.99 M
|
$24.41 M
|
| Selling, General & Administrative Expenses |
$217.94 M
|
$35.92 M
|
$45.16 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$418.77 M
|
$109.32 M
|
$118.88 M
|
| Cost And Expenses |
$512.36 M
|
$145.29 M
|
$140.07 M
|
| Interest Income |
$34.29 M
|
$6.55 M
|
$2.61 M
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$3.15 M
|
$1.78 M
|
$807,000.00
|
| EBITDA |
-$112.91 M |
-$27.72 M |
-$59.39 M |
| EBITDA Ratio |
-0.28
|
-0.24
|
-0.74
|
| Operating Income Ratio |
-0.29
|
-0.25
|
-0.75
|
| Total Other Income/Expenses Net |
$34.29 M
|
$6.55 M
|
$2.61 M
|
| Income Before Tax |
-$81.78 M
|
-$22.95 M
|
-$57.58 M
|
| Income Before Tax Ratio |
-0.21
|
-0.2
|
-0.72
|
| Income Tax Expense |
$1.64 M
|
$3.31 M
|
$764,000.00
|
| Net Income |
-$83.42 M
|
-$26.26 M
|
-$58.35 M
|
| Net Income Ratio |
-0.21
|
-0.23
|
-0.73
|
| EPS |
-0.64 |
-0.71 |
-1.71 |
| EPS Diluted |
-0.64 |
-0.71 |
-1.71 |
| Weighted Average Shares Out |
$131.26 M
|
$37.13 M
|
$34.17 M
|
| Weighted Average Shares Out Diluted |
$131.26 M
|
$37.13 M
|
$34.17 M
|
| Link |
|
|
|
